Ocular Therapeutix Inc (OCUL)

NASDAQ
6.20
+0.04(+0.65%)
After Hours
6.20
0.00(0.00%)
- Real-time Data
  • Volume:
    698,348
  • Bid/Ask:
    6.15/6.20
  • Day's Range:
    5.99 - 6.24

OCUL Overview

Prev. Close
6.16
Day's Range
5.99-6.24
Revenue
38.56M
Open
6.09
52 wk Range
5.99-21.48
EPS
-1.25
Volume
698,348
Market Cap
474.98M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,010,255
P/E Ratio
-
Beta
1.74
1-Year Change
-69.5%
Shares Outstanding
76,610,153
Next Earnings Date
Mar 10, 2022
What is your sentiment on Ocular Therapeutix Inc?
or
Market is currently closed. Voting is open during market hours.

Ocular Therapeutix Inc Company Profile

Employees
181

Ocular Therapeutix, Inc. is a biopharmaceutical company, which is focused on the formulation, development and commercialization of therapies for diseases and conditions of the eye using its proprietary, bioresorbable hydrogel platform technology. The Company’s product pipeline candidates provide differentiated drug delivery solutions. The Company’s products include dexamethasone insert (DEXTENZA) and ReSure Sealant. Its DEXTENZA is an intracanalicular insert for the treatment of post-surgical ocular inflammation and pain. Its ReSure Sealant is an ophthalmic device designed to prevent wound leaks in corneal incisions following cataract surgery. The Company’s products that are in pipeline include OTX-TKI for the treatment of wet AMD, OTX-TIC for the treatment of glaucoma and ocular hypertension, OTX-CSI for the chronic treatment of dry eye disease, and OTX-DED for the short-term treatment of the signs and symptoms of dry eye disease.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuySellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuySellStrong SellStrong Sell
SummaryStrong BuyStrong BuySellStrong SellStrong Sell
  • OCUL (P) 0.00000000 11.25000000
    0
    • Wow!
      0
      • Target?
        0
        • Making a come back. Eye Think so!
          0
          • $6.76 ... nice volume on extended move above 200-day SMA .... market participants must see an approval coming.
            0
            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.